CD274 and neoplasm: This is because programmed death receptor 1 (PD-1) and programmed death ligand 1 (PD-L1) inhibitors bind to PD-1 and PD-L1, respectively, preventing their interaction, restoring the recognition and killing effect of immune cells, avoiding immune escape of tumor cells, and thereby exerting anti-tumor effects (27).